Dalian Bio-Chem subsidiary to invest in chip equipment R&D

Dalian Bio-Chem Co., Ltd. announced its subsidiary, Foshancore Micro-Semiconductor Technology Co., Ltd., plans to sign a cooperative research and development project agreement to develop next-generation dry etching equipment. Foshancore will act as the lead entity, committing its own funds to the project. The initiative, approved by the board on November 17, 2025, involves collaboration with well-known domestic universities and research institutions, with Liu Hongjun, a director and co-general manager of Dalian Bio-Chem, serving as the project leader.

The R&D project is characterized by its long development cycle, substantial investment, and challenging technical hurdles. Potential risks include longer-than-expected development times, failure to meet technical specifications, and even project termination. Financial pressures could arise from fluctuating funding requirements or inadequate cost control. Additionally, there are risks of market misalignment due to rapid technological evolution, difficulties in resource integration among multiple participants, and supply chain issues.

Foshancore Micro-Semiconductor Technology Co., Ltd., established on April 9, 2025, with a registered capital of 3,000 yuan, will establish a dedicated fund account for the project. This strategic investment aligns with Dalian Bio-Chem’s semiconductor business development, aiming to enhance the company's independent innovation capabilities and reinforce its long-term sustainable growth.